Personalis

The firm has received approval for two unspecified clinical tests, with a permit under the molecular genetic testing category.

Researchers compared three open source annotation tools, and also looked at correspondence with public databases, identifying a number of stumbling blocks.

The companies will use Personalis' ACE ImmunoID next-generation sequencing platform to analyze tumor samples from clinical trials of Argos' drug.

The company has been working with the VA since 2013, when it it received a contract to provide sequencing and data analysis for enrollees in the Million Veteran Program.

The companies have signed a letter of intent to offer Personalis' next-generation tumor sequencing and interpretation technology to customers in Canada.

The partners will provide comprehensive clinical genomic testing for tumor profiling and inherited genetic disease at LSU Health New Orleans' Precision Medicine Program.

Compared to commercial exome kits and whole-genome sequencing, the firm's test had improved coverage in medically interpretable genes and the 56 ACMG genes.

In April, Butte became director of UCSF's Institute for Computational Health Sciences and executive director of clinical informatics for UC Health Sciences and Services. 

N-of-One will provide clinical interpretation services for genomic tests conducted as part of the New England Veterans' Integrated Service Network oncology program

If the regional precision medicine program is successful, the VA might expand it for veterans around the country.

Pages

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.